Our in vivo study confirmed the enhanced chemopreventive effect of this combination in prostate-specific PTEN KO mice, as indicated by an increased inhibition of prostate carcinogenesis and Ki67 expression by GT+Q+Arc compared to the control, GT+Q, or Arc alone. The gene discussed is MKI67; the disease is urogenital neoplasm.